Valente ST - Search Results

1

Cure and Long-Term Remission Strategies.

Mori L, Valente ST. Mori L, et al. Among authors: valente st. Methods Mol Biol. 2022;2407:391-428. doi: 10.1007/978-1-0716-1871-4_26. Methods Mol Biol. 2022. PMID: 34985678 Review.

2

Strategies to Block HIV Transcription: Focus on Small Molecule Tat Inhibitors.

Mousseau G, Valente S. Mousseau G, et al. Biology (Basel). 2012 Nov 19;1(3):668-97. doi: 10.3390/biology1030668. Biology (Basel). 2012. PMID: 24832514 Free PMC article.

3

Targeting HIV transcription: the quest for a functional cure.

Mousseau G, Mediouni S, Valente ST. Mousseau G, et al. Among authors: valente st. Curr Top Microbiol Immunol. 2015;389:121-45. doi: 10.1007/82_2015_435. Curr Top Microbiol Immunol. 2015. PMID: 25731772 Free PMC article. Review.

4

The Tat Inhibitor Didehydro-Cortistatin A Prevents HIV-1 Reactivation from Latency.

Mousseau G, Kessing CF, Fromentin R, Trautmann L, Chomont N, Valente ST. Mousseau G, et al. Among authors: valente st. mBio. 2015 Jul 7;6(4):e00465. doi: 10.1128/mBio.00465-15. mBio. 2015. PMID: 26152583 Free PMC article.

5

Didehydro-Cortistatin A: a new player in HIV-therapy?

Mousseau G, Valente ST. Mousseau G, et al. Among authors: valente st. Expert Rev Anti Infect Ther. 2016;14(2):145-8. doi: 10.1586/14787210.2016.1122525. Epub 2015 Dec 11. Expert Rev Anti Infect Ther. 2016. PMID: 26581953 Free PMC article.

6

In Vivo Suppression of HIV Rebound by Didehydro-Cortistatin A, a "Block-and-Lock" Strategy for HIV-1 Treatment.

Kessing CF, Nixon CC, Li C, Tsai P, Takata H, Mousseau G, Ho PT, Honeycutt JB, Fallahi M, Trautmann L, Garcia JV, Valente ST. Kessing CF, et al. Among authors: valente st. Cell Rep. 2017 Oct 17;21(3):600-611. doi: 10.1016/j.celrep.2017.09.080. Cell Rep. 2017. PMID: 29045830 Free PMC article.

7

Modeling HIV-1 Latency Using Primary CD4⁺ T Cells from Virally Suppressed HIV-1-Infected Individuals on Antiretroviral Therapy.

Takata H, Kessing C, Sy A, Lima N, Sciumbata J, Mori L, Jones RB, Chomont N, Michael NL, Valente S, Trautmann L. Takata H, et al. J Virol. 2019 May 15;93(11):e02248-18. doi: 10.1128/JVI.02248-18. Print 2019 Jun 1. J Virol. 2019. PMID: 30918072 Free PMC article.

8

Key Players in HIV-1 Transcriptional Regulation: Targets for a Functional Cure.

Mori L, Valente ST. Mori L, et al. Among authors: valente st. Viruses. 2020 May 11;12(5):529. doi: 10.3390/v12050529. Viruses. 2020. PMID: 32403278 Free PMC article. Review.

9

The XPB Subunit of the TFIIH Complex Plays a Critical Role in HIV-1 Transcription and XPB Inhibition by Spironolactone Prevents HIV-1 Reactivation from Latency.

Mori L, Jenike K, Yeh YJ, Lacombe B, Li C, Getzler A, Mediouni S, Cameron M, Pipkin M, Ho YC, Ramirez BC, Valente S. Mori L, et al. J Virol. 2021 Feb 15;95(4):e01247-20. doi: 10.1128/JVI.01247-20. Epub 2020 Nov 25. J Virol. 2021. PMID: 33239456 Free PMC article.

10

Block-And-Lock: New Horizons for a Cure for HIV-1.

Moranguinho I, Valente ST. Moranguinho I, et al. Among authors: valente st. Viruses. 2020 Dec 15;12(12):1443. doi: 10.3390/v12121443. Viruses. 2020. PMID: 33334019 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

54 results

Search Page

Filters